0001886259-22-000004.txt : 20220818
0001886259-22-000004.hdr.sgml : 20220818
20220818180408
ACCESSION NUMBER: 0001886259-22-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220816
FILED AS OF DATE: 20220818
DATE AS OF CHANGE: 20220818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Benmoussa Kevin
CENTRAL INDEX KEY: 0001886259
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40950
FILM NUMBER: 221178361
MAIL ADDRESS:
STREET 1: C/O THE VITA COCO COMPANY, INC.
STREET 2: 250 PARK AVENUE SOUTH, SEVENTH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vita Coco Company, Inc.
CENTRAL INDEX KEY: 0001482981
STANDARD INDUSTRIAL CLASSIFICATION: BEVERAGES [2080]
IRS NUMBER: 113713156
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 39 WEST 14TH STREET, SUITE 404
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 212-206-0763
MAIL ADDRESS:
STREET 1: 39 WEST 14TH STREET, SUITE 404
CITY: NEW YORK
STATE: NY
ZIP: 10011
FORMER COMPANY:
FORMER CONFORMED NAME: All Market Inc.
DATE OF NAME CHANGE: 20210824
FORMER COMPANY:
FORMER CONFORMED NAME: All Market, Inc.
DATE OF NAME CHANGE: 20210824
FORMER COMPANY:
FORMER CONFORMED NAME: Vita Coco Company, Inc.
DATE OF NAME CHANGE: 20210823
4
1
wf-form4_166086023338835.xml
FORM 4
X0306
4
2022-08-16
0
0001482981
Vita Coco Company, Inc.
COCO
0001886259
Benmoussa Kevin
250 PARK AVENUE SOUTH
7TH FLOOR
NEW YORK
NY
10003
0
1
0
0
Global Chief Financial Officer
Common Stock
2022-08-16
4
M
0
24381
10.178
A
34531
D
Common Stock
2022-08-16
4
S
0
9381
16.01
D
25150
D
Common Stock
2022-08-16
4
S
0
15000
15.11
D
10150
D
Common Stock
2022-08-16
4
M
0
1894
10.178
A
12044
D
Common Stock
2022-08-17
4
S
0
1894
16
D
10150
D
Stock Option (Right to Buy)
10.178
2022-08-16
4
M
0
24381
0
D
2029-12-16
Common Stock
24381.0
59369
D
Stock Option (Right to Buy)
10.178
2022-08-17
4
M
0
1894
0
D
2029-12-16
Common Stock
1894.0
57475
D
Stock Option (Right to Buy)
10.178
2030-02-10
Common Stock
56875.0
56875
D
Stock Option (Right to Buy)
10.178
2031-01-11
Common Stock
27300.0
27300
D
Stock Option (Right to Buy)
15.0
2031-10-20
Common Stock
49751.0
49751
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.03, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.28, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.02, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Includes (i) 10,000 unvested RSUs that vest in four annual installments starting November 27, 2022 provided that the Reporting Person remains in continuous service on each vesting date and (ii) 150 shares of common stock purchased directly from the issuer's underwriters in a Reserved Share Program.
The stock option is fully vested and currently exercisable.
The stock option vests on February 10, 2024.
The stock option vests in two equal biennial installments beginning on January 11, 2023.
The stock option vests in four equal annual installments beginning on November 27, 2022.
/s/ Yolanda Goettsch, Attorney-in-fact
2022-08-18